Table 1.
IC50 values for the inhibition of COX-2 oxygenation of AA and 2-AG by NSAIDs
Inhibitor | 50 μM AA | 50 μM 2-AG | |
---|---|---|---|
reversible | Ibuprofenb,c | 7 μM | 20 nM |
Mefenamic Acidb,c | 180 μM | 210 nM | |
DM-INDO | > 25 μM | 250 nM | |
Lumiracoxib | no inhib. | 40 nM | |
Naproxenb | 4.5 μM | 430 nM | |
SC-58076 | > 4 μM | 40 nM | |
slow, tight binders | Diclofenac | 60 nM | 50 nM |
Flurbiprofen | 130 nM | 30 nM | |
INDO | 180 nM | 30 nM | |
Celecoxib | 80 nM | 95 nM | |
Rofecoxib | 520 nM | 85 nM |
Enzyme and inhibitor were pre-incubated for 15 min prior to the addition of 50 uM substrate for 30 s. Reactions were quenched with organic solvent containing deuterated internal standards. Product formation was analyzed by LC-MS-MS using selected reaction monitoring and normalized to DMSO control.
Substrate oxygenation was measured using an oxygen electrode.
Values for ibuprofen and mefenamic acid taken from 20.